American Journal of Psychiatry · 1987 · 71 citations · 23 references
MedicineNeurologyPharmacotherapyMovement DisordersNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyDrug-induced Movement DisordersParkinsonian DisordersAntipsychotic-induced Tardive DyskinesiaLithium TreatmentProdromal Symptom AnalysisTardive AkathisiaTardive Dyskinesia TreatmentTardive Dystonia
The authors describe 19 patients with severe tardive dyskinesia, 11 of whom had a diagnosis of affective or schizoaffective disorder rather than schizophrenia. Most patients had been receiving long-term neuroleptic treatment with few interruptions and had received only one or two different neuroleptics. Frequent eye blinking was the most prevalent prodromal sign of tardive dyskinesia (in seven patients). Four subtypes of tardive dyskinesia could be distinguished: choreoathetosis, tardive dystonia, blepharospasm, and tardive akathisia. Optimal pharmacotherapy most often consisted of combinations of neuroleptics, lithium carbonate, benzodiazepines, and antiparkinsonian drugs. However, after an average of 62 months, only five patients had markedly improved.
23
Robert E. Burke, Stanley Fahn, Joseph Jankovic et al. · Neurology · 1982 · 603 citations
Medicine, Neurology, Pharmacotherapy +15
SPONTANEOUS EYE-BLINK RATES AND DOPAMINERGIC SYSTEMS
Craig N. Karson · Brain · 1983 · 524 citations
Medicine, Neuroscience, Pharmacology +14
Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity
Agu Pert, Jack E. Rosenblatt, Carlos Sivit et al. · Science · 1978 · 287 citations
Medicine, Neuroscience, Pharmacology +17
Akathisia Variants and Tardive Dyskinesia
Thomas R. E. Barnes · Archives of General Psychiatry · 1985 · 259 citations
Medicine, Neurology, Psychiatry +12